Proposal to amend List A (List of certain antimicrobial active ingredients) – Proposed List A 2022
I. Proposed additions to List A
List A will be amended by inserting new antimicrobial active pharmaceutical ingredients and antibacterial classes listed below.
Drugs containing any of the following: | Including (but not limited to) |
---|---|
Aminoglycosides | Fortimicin |
Plazomicin | |
Beta-lactamase inhibitors | Durlobactam |
Enmetazobactam | |
Nacubactam | |
Relebactam | |
Taniborbactam | |
Zidebactam | |
Benzimidazoles | Ridinilazole |
Benzofuran naphthyridines | Afabicin |
Carbapenems | Benapenem |
Tebipenem pivoxil | |
Cephalosporins - fourth generation | Cefiderocol |
Diketopiperazines | Bicyclomycin (Bicozamycin) |
DNA polymerase inhibitors | Ibezapolstat |
Fluoroquinolones | Alalevonadifloxacin |
Antofloxacin | |
Aravofloxacin | |
Balofloxacin | |
Clinafloxacin | |
Levonadifloxacin | |
Zabofloxacin | |
Glycopeptides | Cefilavancin |
Norvancomycin | |
Ketolides | Nafithromycin |
Monobactams | Ancremonam |
Nitrofurans | Nitrofurazone |
Nitroimidazoles | Morinidazole |
Oxazolidinones | Contezolid |
Contezolid acefosamil | |
Delpazolid | |
Sutezolid | |
Penems | Sulopenem etzadroxil |
Peptidomimetics | Brilacidin |
Murepavaidin | |
Pleuromutilins | Lefamulin |
Quinolinols | Nitroxoline |
Quinolones | Nemonoxacin |
Spiropyrimidinetriones | Zoliflodacin |
Sulfonamides | Sulfabenzamide |
Tetracyclines - newer generations | Eravacycline |
Omadacycline | |
Sarecycline | |
Therapeutic agents for tuberculosis | Clofazimine |
Delaminid | |
Macozinone | |
Perchlozone | |
Pretomanid | |
Telacebec | |
Triazaacenaphthylenes | Gepotidacin |
II. Proposed revisions to existing antimicrobial active ingredients on List A
Drugs containing any of the following: | Including (but not limited to) | Amendment (comments) |
---|---|---|
Aminoglycosides | Apramycin | Old drug (re-classify previously aminocyclitols) |
Hygromycin B | Old drug (re-classify previously aminocyclitols) |
Page details
- Date modified: